Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Adalimumab versus ustekinumab as first-line biological in moderate-to-severe Crohn's disease: real-life cohort from a tertiary referral center

Annick Moens,Dahham Alsoud,Bram Verstockt,João Sabino,Marc Ferrante,Séverine Vermeire

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY（2022）

Cited 4|Views9
No score
Key words
adalimumab, Crohn's disease, first, line, SEAVUE, ustekinumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined